Popular Zantac Alternative Drugs May Cause Type-2 Diabetes

Just when you thought nothing bad would happen if you switched heartburn medicines, PPI drugs have become linked to developing diabetes

Saturday, October 10, 2020 - In 2019, online drug testing pharmacy Valisure found levels of a carcinogenic substance called NDMA many times greater than the allowable FDA limit in ranitidine. Ranitidine is sold mostly under the brand name Zantac. When Zantac (ranitidine) was recalled earlier in the year by the US Food and Drug Administration (FDA) for fear of causing cancer, heartburn and acid-reflux patients searched for alternatives to treat their painful condition. The FDA recommended switching to heartburn drugs that had not tested positive for excessive levels of NDMA, a known carcinogen, considering them a safe Zantac alternative. The FDA told readers, "Consumers taking over-the-counter (OTC) ranitidine may consider using other OTC products approved for their condition. FDA's tests of samples of alternatives such as Pepcid (famotidine), Tagamet (cimetidine), Nexium (esomeprazole), Prevacid (lansoprazole) and Prilosec (omeprazole) show no NDMA in the medicines to date." The news of switching drugs was welcome by Zantac customers, but now they have a new disease to fear. Zantac users may have been trading the risk of developing cancer for the risk of developing diabetes when they switched heartburn medicines according to a report published today on Newsmax.com (NM). Heartburn medicine cancer lawyers offer a free consultation with no obligation to file a claim.

According to Newsmax (NM), a newly-released study claims that using Pepcid, Tagamet, Nexium, Prevacid, and Prilosec may lead to developing Type-2 diabetes. Experts tell us that Type-2 diabetes causes problems for the capillaries and the smallest veins in the eyes, kidney, and nervous system and also increases the risk of heart attack and stroke. "Chinese researchers drew on information from studies of more than 200,000 U.S. health care professionals and found that regular use of PPIs (such as Aciphex, Nexium, Prilosec, Prevacid, Protonix) was associated with a 24% higher risk of developing type 2 diabetes." Long-term PPI drug usage is also associated with "bone fractures, kidney disease, digestive tract infections, and stomach cancer," according to NM. People that insist on taking Zantac alternative medicines should see their doctor once per month and have diabetes blood screening. By now everyone should know that changing one's diet to include more fruits and vegetables and less meat, spicy food, caffeine, and alcohol will go along way to eliminating the need for diabetes or heartburn medicine.

Former Zantac users are seeking guidance from knowledgeable Zantac Cancer attorneys around the country for help filing a claim against French Pharmaceutical giant Sanofi. Plaintiffs allege that taking Zantac regularly and for more than one year caused them to develop a variety of forms of cancer. Plaintiffs allege Zantac causes stomach, bladder, esophagus, intestinal, colon, prostate, and breast cancer.

If you or a loved one have taken Zantac regularly and developed cancer you should know that lawsuits are forming around the country into multidistrict litigation as the science behind Zantac NDMA cancer is common to all users of the drug. A Zantac Cancer lawyer stands ready to add your case to the group if you so qualify.

More Recent Heartburn MedicineLawsuit News:

• Zantac Cancer Trials Are In Discovery To Begin In October 2022 | 7/19/2022
• Zantac Cancer Lawsuits Could Hinge On The Validity of Ranitidine Testing Methods | 7/11/2022
• Zantac Cancer Bellwether Trials In California Could Set The Stage For A Global Settlement Offer | 7/5/2022
• The FDA Recommended Protein Pump Inhibitor Drugs Like Prilosec And Nexium That May Damage Health More Than Zantac | 6/23/2022
• Truck Drivers, Firefighters, and Police Officers May Have Taken More Zantac Than People In Other Occupations | 6/20/2022
• Scientists Are Expected To Confirm That Ranidine Causes Gastrointestinal Cancer With Slam Dunk Testimony | 6/9/2022
• Scientific Hearings Will Start This September To Interview Zantac Cancer Expert Witnesses | 5/19/2022
• A Whistleblower Scientist Working For A Chinese Company Thinks NDMA Contamination Started In China | 5/12/2022
• Valisure's String Of Stunning Success Casts Doubt On The FDAs Ability To Police The Health Care Market | 5/2/2022
• Zantac Testing Accusations Heat Up With FDA Investigation Of Online Prescription Drug Testing Lab | 4/25/2022
• Study Finds Ranitidine Degrades Into 10,000 Nanograms of NDMA When Introduced To Simulated Stomach Conditions | 4/6/2022
• Potential Zantac Expert Witnesses Are Being Questioned By Zantac Defense Attorneys | 3/31/2022
• The FDA Requires That Drug Companies Regularly Test Ranitidine And Other Drug For NDMA | 3/24/2022
• Update: Where The Zantac Cancer Multidistrict Litigation (MDL) Stands Today | 3/12/2022
• Zantac Cancer Plaintiffs Look To The First Trial In October In Alameda California | 3/11/2022
• Zantac Cancer Plaintiffs Have Until June 30 To Finalize Their Claim | 3/7/2022
• Zantac Bellwether Trials May Focus On Ranitidine Testing Methods That Could Cause NDMA To Accelerate | 3/1/2022
• Valisure LLC's Motivations And Ranitidine Testing Methods May Not Be Scrutinized Before Trial | 2/24/2022
• Zantac Lawsuits May Go To Trial In California In October Of This Year | 2/18/2022
• Sanofi's History Of Reprehensible Corporate Behavior May Bolster Zantac Cancer Lawsuits | 2/10/2022

Lawyers for Zantac Heartburn Medicine Lawsuits

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.